Humana Inc. HUM

Full chart Compare
Set alert

Price alert · HUM

All alert types
417.87 USD +7.46 (+1.82%)

At closeNov 3, 2026, 4:00 PM EST

417.87 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

407.36 Day range 422.65
163.11 52-week range 456.50
YTD
+63.15%
1 year
+49.28%
Market cap
50.18B
Revenue (ttm)
145.68B
Profit margin
0.88%
EPS (ttm)
10.58
Shares out
120.08M
P/E ratio
39.50
Forward P/E
24.46
Dividend
3.54 (0.86%)
Ex-dividend date
Dec 23, 2026
YTD return
+63.15%
1-year return
+49.28%
Volume
1.37M
Avg volume
1.24M
Open
407.87
Previous close
410.41
Day's range
407.36 – 422.65
52-week range
163.11 – 456.50
Beta
0.64
Analysts
Buy
Price target
465.13 (+11.3%)
Earnings date
Nov 6, 2026

5D -0.36 (-0.09%)

400410420WedThuFriMonTue417.66

Key statistics

Enterprise value
40.22B
PEG ratio
1.13
Price / sales
0.34
Price / book
2.61
Dividend yield
0.86%
Payout ratio
33.46%
Revenue growth
26.20%
Free cash flow
1.94B
Total cash
23.87B
Total debt
14.74B
Return on equity
6.89%
Short % of float
3.47%
50-day average
401.66
200-day average
308.97

Financials — quick view

All financials
HUM Revenue — quarterly 40.87B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HUM Net income — quarterly 694.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HUM EPS — quarterly 5.78
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

HUM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2026Sep 30, 2026-1.00———
Jul 29, 2026Jun 30, 20267.277.61+0.34+4.68%
Apr 29, 2026Mar 31, 202610.2410.31+0.07+0.68%
Feb 11, 2026Dec 31, 2025-4.00-3.96+0.04+1.00%
Nov 5, 2025Sep 30, 20252.933.24+0.31+10.58%
Jul 30, 2025Jun 30, 20255.926.27+0.35+5.91%

Upgrades / downgrades

HUM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026MizuhomainOutperformOutperform
Oct 12, 2026UBSmainNeutralNeutral
Oct 12, 2026Truist SecuritiesmainHoldHold
Oct 12, 2026OppenheimermainOutperformOutperform
Oct 12, 2026Raymond JamesupMarket PerformOutperform
Oct 9, 2026BarclaysmainOverweightOverweight

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States
Website
humana.com

News

Your note

Sign in to keep a note on HUM — it syncs with the Stock Master app.

Insider holders

HUM insider holders
InsiderRelationLatest transactionDateShares held
BROWN CELESTE MChief Financial OfficerStock Award(Grant)Feb 12, 202523,291
DIAMOND SUSAN MChief Financial OfficerConversion of Exercise of derivative securityDec 12, 202422,378
DINTENFASS DAVIDOfficerStock Award(Grant)Apr 30, 202625,407
MARTIN AARONOfficerStock Award(Grant)Apr 30, 202625,237
MEHTA JAPANChief Technology OfficerStock Award(Grant)Apr 30, 202617,176
MELLET CELESTEChief Financial OfficerStock Award(Grant)Apr 30, 202639,637

Institution ownership

HUM institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.9.11%10,940,3804.57BJun 29, 2026
Blackrock Inc.8.68%10,417,8034.35BJun 29, 2026
Vanguard Capital Management LLC6.53%7,843,6203.28BJun 29, 2026
Vanguard Portfolio Management LLC4.85%5,818,9562.43BJun 29, 2026
State Street Corporation4.54%5,457,0722.28BJun 29, 2026
Eagle Capital Management LLC3.20%3,846,7621.61BJun 29, 2026

Fund ownership

HUM fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund6.12%7,354,5003.07BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%3,811,7111.59BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%3,111,6591.30BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.17%2,601,4731.09BJun 29, 2026
AMERICAN FUNDS FUNDAMENTAL INVESTORS1.41%1,690,812706.71MSep 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%1,600,377668.91MSep 29, 2026